Published in Heart Fail Rev on October 01, 2002
Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury. J Mol Cell Cardiol (2007) 1.59
Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats. J Biomed Biotechnol (2011) 0.97
Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction. J Cell Mol Med (2010) 0.91
Neonatal asphyxia induces the nitration of cardiac myosin light chain 2 that is associated with cardiac systolic dysfunction. Shock (2010) 0.88
SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats. Cardiovasc Diabetol (2015) 0.88
Protective effects of chinese traditional medicine buyang huanwu decoction on myocardial injury. Evid Based Complement Alternat Med (2011) 0.86
Effect of thrombin fragment (TP508) on myocardial ischemia-reperfusion injury in hypercholesterolemic pigs. J Appl Physiol (1985) (2009) 0.84
Protective effects of low-frequency magnetic fields on cardiomyocytes from ischemia reperfusion injury via ROS and NO/ONOO-. Oxid Med Cell Longev (2013) 0.83
Catestatin increases the expression of anti-apoptotic and pro-angiogenetic factors in the post-ischemic hypertrophied heart of SHR. PLoS One (2014) 0.82
The influence of recovery and training phases on body composition, peripheral vascular function and immune system of professional soccer players. PLoS One (2009) 0.81
Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells. World J Gastroenterol (2006) 0.81
Fluid Mechanical Forces and Endothelial Mitochondria: A Bioengineering Perspective. Cell Mol Bioeng (2014) 0.81
Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb. BMC Musculoskelet Disord (2013) 0.80
Glucagon effects on ischemic vasodilatation in the isolated rat heart. J Biomed Biotechnol (2010) 0.80
Circulating NOS3 modulates left ventricular remodeling following reperfused myocardial infarction. PLoS One (2015) 0.79
Hypoxic conditioning suppresses nitric oxide production upon myocardial reperfusion. Exp Biol Med (Maywood) (2008) 0.79
Effect of thrombin fragment (TP508) on myocardial ischemia reperfusion injury in a model of type 1 diabetes mellitus. Circulation (2010) 0.78
Cardioprotective Effect of High Intensity Interval Training and Nitric Oxide Metabolites (NO2 (-), NO3 (-)). Iran J Public Health (2015) 0.77
Nitric oxide in heart failure: friend or foe. Heart Fail Rev (2002) 0.77
Nitric oxide and cardiovascular protection. Heart Fail Rev (2003) 0.77
Non-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz). PLoS One (2015) 0.76
The role of nitric oxide in endotoxin-induced cardiodepression. Exp Clin Cardiol (2005) 0.75
Apoptosis after reperfused myocardial infarction: Role of angiotensin II. Exp Clin Cardiol (2004) 0.75
Glucagon effects on 3H-histamine uptake by the isolated guinea-pig heart during anaphylaxis. Biomed Res Int (2014) 0.75
Nitric Oxide is Necessary for Diazoxide Protection Against Ischemic Injury in Skeletal Muscle. Iran J Pharm Res (2012) 0.75
Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A (1990) 16.34
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22
Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell (1991) 13.70
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol (1996) 13.14
Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med (1985) 11.68
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res (2000) 10.95
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (1986) 9.93
Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 9.86
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med (2001) 9.75
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol (1990) 8.85
NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res (2000) 8.62
Nitric oxide synthases: roles, tolls, and controls. Cell (1994) 8.36
Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 8.04
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell (1995) 7.13
Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20
Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1996) 5.94
Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science (1989) 5.61
The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation (1982) 5.56
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet (2000) 5.42
Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (1990) 5.17
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest (1995) 5.09
Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest (1989) 5.01
Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys (1991) 4.71
The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest (1974) 4.42
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature (1998) 4.34
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
Myocardial reperfusion: a double-edged sword? J Clin Invest (1985) 4.12
Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation (1992) 3.73
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A (1992) 3.72
Control of coronary vascular tone by nitric oxide. Circ Res (1990) 3.64
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A (1995) 3.53
Apoptosis in ischemic and reperfused rat myocardium. Circ Res (1996) 2.85
Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem (1988) 2.80
Nitric oxide synthase activities in human myocardium. Lancet (1993) 2.72
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation (1991) 2.62
Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension (2001) 2.61
Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci U S A (1988) 2.34
Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem (1996) 2.33
Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation (1996) 2.31
Mechanism of myocardial "stunning". Circulation (1990) 2.16
Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci U S A (1991) 2.15
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A (1995) 2.14
Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem (1995) 2.11
Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation (1998) 2.08
Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology (1994) 2.07
Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation (2001) 2.06
Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation (1996) 2.06
Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest (1988) 2.02
Nitric oxide and cardiac function. Circ Res (1996) 2.01
Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res (1998) 2.01
Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol (1985) 2.00
Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation (1999) 1.96
Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation (1987) 1.90
Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation (1986) 1.88
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest (1997) 1.83
Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res (1998) 1.80
Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation (1994) 1.79
Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem (1996) 1.78
Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res (1999) 1.77
Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation (2001) 1.77
Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectin. Nature (1991) 1.76
Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ Res (2002) 1.74
Reperfusion of the ischemic myocardium. J Mol Cell Cardiol (1977) 1.74
Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest (2002) 1.70
Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol (1998) 1.69
Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest (1998) 1.68
Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation (1989) 1.68
Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation (1980) 1.67
Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest (1998) 1.65
Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am J Physiol (1989) 1.65
Nitric oxide as a bifunctional regulator of apoptosis. Circ Res (1999) 1.63
Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res (1993) 1.63
Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol (1989) 1.58
Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation (1996) 1.57
Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J (1992) 1.53
Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem (1996) 1.53
Mediation of cardioprotection by transforming growth factor-beta. Science (1990) 1.52
Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem (1994) 1.49
Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res (1999) 1.48
Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest (1991) 1.48
Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res (1997) 1.47
Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest (1995) 1.47
Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation (1992) 1.40
Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation (1989) 1.40
Nuclear factor-kappa B. Int J Biochem Cell Biol (1997) 1.39
Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol (1990) 1.37
Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension (1991) 1.36
Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation (1993) 1.34
Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med (1991) 1.33
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation (1990) 1.31
Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res (2002) 1.30
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation (1992) 1.28
Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther (1990) 1.26
Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol (1998) 1.26
Inhibitory action of guanosine 3', 5'-monophosphate on thrombin-induced phosphatidylinositol turnover and protein phosphorylation in human platelets. Biochem Biophys Res Commun (1981) 1.25
Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest (1997) 1.24